X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
WYETH LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

WYETH LIMITED  (WYLD)


Here is the latest financial fact sheet of WYETH LTD. For more details, see the WYETH LTD quarterly results and WYETH LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
wyeth ltd - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 1,334.6       No. of shares m 22.72
    Mkt Cap Rs m 30,322       % ch % -2.3
    Vol '000 6.2       % ch week % 7.5
    P/E X 27.7       % ch 1-mth % 18.6
    P/CF X 22.8       % ch 12-mth % 69.6
    EPS (TTM) Rs 48.1       52 week H/L Rs 1,409.0/688.3
(As on Dec 9, 2014 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-09
8
Nov-09
16
Mar-11
12
Mar-12
12
Mar-13
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs5097739001,0751,044 
Low Rs348414691794818 
Sales per share (Unadj.) Rs168.4126.0282.2259.0298.6 
Earnings per share (Unadj.) Rs43.926.072.863.757.2 
Diluted earnings per shareRs43.926.072.863.757.2 
Cash flow per share (Unadj.) Rs46.928.976.766.358.4 
Dividends per share (Unadj.) Rs32.5020.0022.0018.0017.00 
Adj. dividends per shareRs32.5020.0022.0018.0017.00 
Dividend yield (eoy) %7.63.42.81.91.8 
Book value per share (Unadj.) Rs119.6122.1169.4212.1249.5 
Adj. book value per shareRs119.6122.1169.4212.1249.5 
Shares outstanding (eoy) m22.7222.7222.7222.7222.72 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x2.54.72.83.63.1 
Avg P/E ratio x9.822.910.914.716.3 
P/CF ratio (eoy) x9.120.510.414.115.9 
Price / Book Value ratio x3.64.94.74.43.7 
Dividend payout %74.177.030.228.329.7 
Avg Mkt Cap Rs m9,73613,48418,07421,23221,157 
No. of employees `0000.80.80.50.50.5 
Total wages/salary Rs m428347513377400 
Avg. sales/employee Rs Th4,638.23,522.312,524.411,339.713,787.4 
Avg. wages/employee Rs Th519.2426.91,001.8727.2813.0 
Avg. net profit/employee Rs Th1,208.2725.73,228.32,788.12,643.3 
  INCOME DATA
Net Sales Rs m3,8272,8646,4135,8856,783 
Other income Rs m215100199340353 
Total revenues Rs m4,0422,9646,6126,2257,136 
Gross profit Rs m1,2867872,2831,7781,617 
Depreciation Rs m6968905927 
Interest Rs m431356 
Profit before tax Rs m1,4298172,3802,0541,938 
Minority Interest Rs m00000 
Prior Period Items Rs m01000 
Extraordinary Inc (Exp) Rs m-50-23-5-5 
Tax Rs m427229704602632 
Profit after tax Rs m9975901,6531,4471,301 
Gross profit margin %33.627.535.630.223.8 
Effective tax rate %29.928.029.629.332.6 
Net profit margin %26.020.625.824.619.2 
  BALANCE SHEET DATA
Current assets Rs m3,8783,6454,1325,6716,984 
Current liabilities Rs m1,5801,2419191,4292,056 
Net working cap to sales %60.084.050.172.172.6 
Current ratio x2.52.94.54.03.4 
Inventory Days Days5376427499 
Debtors Days Days2325193424 
Net fixed assets Rs m389326271257244 
Share capital Rs m227227227227227 
"Free" reserves Rs m2,4902,5483,6214,5925,441 
Net worth Rs m2,7172,7753,8484,8195,668 
Long term debt Rs m2525252525 
Total assets Rs m4,3224,0414,9946,4937,901 
Interest coverage x358.2292.9191.4428.9353.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.71.30.90.9 
Return on assets %23.214.733.322.416.5 
Return on equity %36.721.343.030.022.9 
Return on capital %52.129.361.242.434.0 
Exports to sales %0.20.20.40.10.2 
Imports to sales %21.121.922.728.436.3 
Exports (fob) Rs m8628815 
Imports (cif) Rs m8096281,4561,6742,465 
Fx inflow Rs m96291115 
Fx outflow Rs m1,2031,0511,9111,7822,677 
Net fx Rs m-1,194-1,044-1,882-1,772-2,662 
  CASH FLOW
From Operations Rs m 602 578 1,510 764 923 
From Investments Rs m 142 101 115 313 317 
From Financial Activity Rs m -801 -863 -936 -188 -481 
Net Cashflow Rs m -57 -184 689 889 759 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for wyeth limited

 Raw Materials Data
Top
ITEM Rs m % To R.M.C. % To SALES
Levonogestrel/nogestrel 37.0 4.5 0.5
Others 240.6 29.5 3.4
Prednisolone 538.4 66.0 7.7

 Share Holding
Indian Promoters : 0.0%
Foreign collaborators : 51.1%
Indian inst/Mut Fund : 11.3%
FIIs : 7.2%
ADR/GDR : 0.0%
Free float : 30.4%
Shareholders : 21,978
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Level 6, Platina, Plot No. C-59, G Block, BKC, Bandra (E), Mumbai - 400 098
    E-MAIL: thakorn@wyeth.com     WEB: www.wyethindia.com
    TELEPHONE: (022) 2657 4000     FAX: (022) 2657 4100
    SECTOR: PHARMACEUTICALS     GROUP: M N C
    TR AGENT: Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
    AUDITOR: B. S. R & Assoc.
CHM: Pradip Shah COMP SEC: Neema Thakore YEAR OF INC: 1947 BSE CODE: 500095 FV (Rs): 10 DIV YIELD (%): 1.3

More pharmaceuticals Company Fact Sheets:   VENUS REMEDIESSUVEN LIFENOVARTISALEMBIC PHARMASUN PHARMA


Today's Market

Global Markets Ends the Week Higher on the Back of French Election Results(RoundUp)

Financial markets received a boost earlier in the week by news that centrist Emmanuel Macron had triumphed over far-right candidate Marine Le Pen in the first round of France's presidential election.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

We Don't Want More F&O Stocks... We Need Smaller Lot Sizes(Daily Profit Hunter)

Apr 26, 2017

Are you excited to trade in the sixteen new stocks to be introduced in the F&O segment this Friday?

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WYETH LTD

WYETH LTD 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE WYETH LTD WITH

MARKET STATS